Empowered Funds, LLC Dynavax Technologies Corp Transaction History

Empowered Funds, LLC

  • $6.17 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 01, 2023
BUY
$12.64 - $14.99 $38,804 - $46,019
3,070 Added 1.67%
187,047 $2.76 Million
Q2 2023

Jul 27, 2023
BUY
$9.85 - $13.17 $1.06 Million - $1.41 Million
107,405 Added 140.27%
183,977 $2.38 Million
Q1 2023

Apr 05, 2023
BUY
$9.44 - $11.88 $722,839 - $909,675
76,572 New
76,572 $751,000

Others Institutions Holding DVAX

# of Institutions
275
Shares Held
130M
Call Options Held
451K
Put Options Held
203K
View Full List

About DYNAVAX TECHNOLOGIES CORP

DVAX Quotes by TradingView
  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.61B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Empowered Funds, LLC Portfolio

Follow Empowered Funds, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Empowered Funds, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Empowered Funds, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email